Latest News and Press Releases

Current Shareholder of RE/MAX? Contact BFA Law about its Ongoing Investigation into the Board Over $13.80 per share Merger

The RE/MAX Board may have Breached its Fiduciary Duties to Investors – Contact BFA Law about its Pending Investigation into the Merger

The Select Medical Board may have Breached its Fiduciary Duties to Investors – Contact BFA Law about its Pending Investigation into the Merger

Select Medical $16.50 Merger Announcement Triggers Investigation into the Board on behalf of Current Shareholders – Contact BFA Law

RE/MAX Holdings $13.80 Merger Announcement Triggers Investigation into the Board on behalf of Current Shareholders – Contact BFA Law

BFA Law is Investigating the Select Medical Merger – Current Shareholders are Notified to Contact the Firm

BFA Law is Investigating the RE/MAX Holdings Merger – Current Shareholders are Notified to Contact the Firm

Did the RE/MAX Holdings Board Breach its Duties to Investors? BFA Law Notifies Current Shareholders of the Pending Investigation into Merger

he RE/MAX Holdings Board may have Breached its Fiduciary Duties in Upcoming Merger – Contact BFA Law about its Pending Investigation

Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline